NCT03707457 2020-07-02Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of GlioblastomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Terminated3 enrolled